// App-Quantinova.ai

10548 : Outcomes for young children with molecularly defined ependymoma treated on the multi-institutional SJYC07 clinical trial.

Researchers

Presenter

  • Santhosh Upadhyaya

Principal Investigators

  • Brent Orr

  • Arzu Onar-Thomas

  • Catherine A Billups

  • Gregory T. Armstrong

  • Zsila Sousan Sadighi

  • Tim Hassall

  • Daniel C. Bowers

  • Anne Elizabeth Bendel

  • John R Crawford

  • Sonia Partap

  • Paul Klimo

  • Julie H Harreld

  • Christopher L Tinkle

  • Daniel J. Indelicato

  • Frederick A Boop

  • Thomas E. Merchant

  • David W. Ellison

  • Amar J. Gajjar

Medical Centers

  • St. Jude Children's Research Hospital, Memphis, TN

  • St. Jude Children's Research Hospital, Memphis, TN

  • Lady Cilento Childrens Hospital, Brisbane, Australia

  • The University of Texas Southwestern Medical Center, Dallas, TX

  • Children's Hosp and Clinics, Minneapolis, MN

  • UC San Diego Moores Cancer Cancer, La Jolla, CA

  • Stanford Univ, Palo Alto, CA

  • University of Florida Health Proton Therapy Institute, Jacksonville, FL

Locations

  • United States

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • DNA methylation

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Methotrexate

  • Vincristine

  • Cisplatin

  • Topotecan Hydrochloride

Outcome

  • N/A


Study Design

  • Multicenteric

Phase

  • NA

Study Id's

  • NCT00602667

Sponsors

  • N/A

Result

  • Final